Skip to main content
Year archive

U2BIO CO., LTD. — 2025 filings

All 31 regulatory filings released by U2BIO CO., LTD. (221800) in 2025, sourced directly from the official regulator.

31 Filings
2025 Period
2025 filings (31)
Filing Released Lang
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-12-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-12-31 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-12-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-12-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-12-31 Korean
최대주주변경
Board/Management Information
2025-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2025-12-16 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2025-12-16 Korean
주주총회소집공고
AGM Information
2025-12-16 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-11-07 Korean
증권발행결과(자율공시) (제3자배정 유상증자)
Regulatory Filings
2025-11-06 Korean
소송등의판결ㆍ결정 (신주발행금지가처분)
Regulatory Filings
2025-11-06 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-11-05 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-11-04 Korean
[기재정정]주요사항보고서(유상증자결정)
Regulatory Filings
2025-11-04 Korean
주요사항보고서(소송등의제기)
Regulatory Filings
2025-11-03 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-11-03 Korean
주요사항보고서(유상증자결정)
Regulatory Filings
2025-10-29 Korean
주요사항보고서(타법인주식및출자증권양수결정)
Regulatory Filings
2025-10-29 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-09-11 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2025-03-28 Korean
사업보고서 (2024.12)
Annual Report FY 2024
2025-03-20 Korean
주주총회집중일개최사유신고
AGM Information
2025-03-13 Korean
주주총회소집공고
AGM Information
2025-03-13 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2025-02-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2024
2025-02-05 Korean